Page 92 - ITPS-7-4

INNOSC Theranostics and
Pharmacological Sciences Digital therapeutics for obesity management

glucose control. Diabetes Care. 2011;34:1934-1942. doi: 10.1089/tmj.2008.0099
doi: 10.2337/dc11-0366 18. Ku EJ, Park JI, Jeon HJ, Oh T, Choi HJ. Clinical efficacy
and plausibility of a smartphone-based integrated online
7. Wang C, Lee C, Shin H. Digital therapeutics from bench to real-time diabetes care system via glucose and diet data
bedside. NPJ Digit Med. 2023;6(1):38.
management: A pilot study. Intern Med J. 2020;50:1524-1532.
doi: 10.1038/s41746-023-00777-z
doi: 10.1111/imj.14738
8. European Data Protection Supervisor. Digital Therapeutics 19. Guo H, Zhang Y, Li P, Zhou P, Chen LM, Li SY. Evaluating
(DTx); 2022. Available from: https://edps.europa.eu/ the effects of mobile health intervention on weight
press-publications/publications/techsonar/digital- management, glycemic control and pregnancy outcomes
therapeuticsdtx_en [Last accessed on 2024 Jun 02].
in patients with gestational diabetes mellitus. J Endocrinol
9. Ministry of Food and Drug Safety (Korea). Guideline Invest. 2019;42:709-714.
on Review and Approval of Digital Therapeutics (For doi: 10.1007/s40618-018-0975-0
Industry); 2020. Available from: https://www.mfds.go.kr/
eng/brd/m_40/view.do?seq=72624&srchfr=&srchto 20. Kirwan M, Vandelanotte C, Fenning A, Duncan MJ. Diabetes
=& sr c hw o r d=& sr c ht p =&i t m _s e q_ 1=0 &i t m_ self-management smartphone application for adults with
seq_2=0&multi_itm_seq=0&company_cd=&company_ type 1 diabetes: Randomized controlled trial. J Med Internet
nm=&page=1 [Last accessed on 2024 Jun 02]. Res. 2013;15:e235.
10. Digital Therapeutics Alliance. Digital Therapeutics Definition doi: 10.2196/jmir.2588
and Core Principles; 2019. Available from: https://dtxalliance. 21. Kim M, Kim Y, Go Y, et al. Multidimensional cognitive
org [Last accessed on 2024 Jun 02]. behavioral therapy for obesity applied by psychologists
11. Dang A, Arora D, Rane P. Role of digital therapeutics and using a digital platform: Open-label randomized controlled
the changing future of healthcare. J Family Med Prim Care. trial. JMIR Mhealth Uhealth. 2020;8:e14817.
2020;9(5):2207-2213. doi: 10.2196/14817
doi: 10.4103/jfmpc.jfmpc_105_20 22. Sepah SC, Jiang L, Ellis RJ, McDermott K, Peters AL.
12. Lottes AE, Cavanaugh KJ, Chan YY, et al. Navigating the Engagement and outcomes in a digital diabetes prevention
regulatory pathway for medical devices-a conversation program: 3-year update. BMJ Open Diabetes Res Care.
with the FDA, clinicians, researchers, and industry experts. 2017;5(1):e000422.
J Cardiovasc Transl Res. 2022;15(5):927-943. doi: 10.1136/bmjdrc-2017-000422
doi: 10.1007/s12265-022-10232-1 23. May CN, Cox-Martin M, Ho AS, et al. Weight loss
13. Kepplinger EE. FDA’s expedited approval mechanisms for maintenance after a digital commercial behavior change
new drug products. Biotechnol Law Rep. 2015;34(1):15-37. program (Noom Weight): Observational cross-sectional
survey study. Obes Sci Pract. 2023;9(5):443-451.
doi: 10.1089/blr.2015.9999
doi: 10.1002/osp4.666
14. Burns L, Le Roux N, Kalesnik-Orszulak R, et al. Real-
world evidence for regulatory decision-making: Updated 24. Quinn CC, Clough SS, Minor JM, Lender D, Okafor MC,
guidance from around the world. Front Med (Lausanne). Gruber-Baldini A. WellDoc mobile diabetes management
2023;10:1236462. randomized controlled trial: Change in clinical and
behavioral outcomes and patient and physician satisfaction.
doi: 10.3389/fmed.2023.1236462 Diabetes Technol Ther. 2008;10(3):160-168.
15. Castelnuovo G, Pietrabissa G, Manzoni GM, et al. doi: 10.1089/dia.2008.0283
Cognitive behavioral therapy to aid weight loss in obese
patients: Current perspectives. Psychol Res Behav Manag. 25. Kumbara AB, Iyer AK, Green CR, et al. Impact of a combined
2017;10:165-73. continuous glucose monitoring-digital health solution on
glucose metrics and self-management behavior for adults
doi: 10.2147/PRBM.S113278 with type 2 diabetes: Real-world, observational study. JMIR
Diabetes. 2023;8:e47638.
16. Garabedian LF, Ross-Degnan D, Wharam JF. Mobile
phone and smartphone technologies for diabetes care and doi: 10.2196/47638
selfmanagement. Curr Diab Rep. 2015;15:109.
26. Levine BJ, Close KL, Gabbay RA. Reviewing U.S. Connected
doi: 10.1007/s11892-015-0680-8 diabetes care: The newest member of the team. Diabetes
17. Holtz B, Lauckner C. Diabetes management via mobile Technol Ther. 2020;22:1-9.
phones: A systematic review. Telemed J E Health. 27. Arigo D, Jake-Schoffman DE, Wolin K, Beckjord E,
2012;18:175-184. Hekler EB, Pagoto SL. The history and future of digital

Volume 7 Issue 4 (2024) 9 doi: 10.36922/itps.4042